InspireMD, Inc. (NSPR)
Largest Insider Buys in Sector
NSPR Stock Price History Chart
NSPR Stock Performance
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as …
Insider Activity of InspireMD, Inc.
Over the last 12 months, insiders at InspireMD, Inc. have bought $126,540 and sold $0 worth of InspireMD, Inc. stock.
On average, over the past 5 years, insiders at InspireMD, Inc. have bought $365,935 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: ROUBIN GARY S (director) — $126,540.
The last purchase of 50,000 shares for transaction amount of $126,540 was made by ROUBIN GARY S (director) on 2023‑11‑30.
List of Insider Buy and Sell Transactions, InspireMD, Inc.
| 2023-11-30 | director | 50,000 0.2339% | $2.53 | $126,540 | +2.93% | |||
| 2023-05-12 | director | 175,000 2.5032% | $1.63 | $285,723 | +85.52% | |||
| 2023-05-12 | director | 61,249 0.8761% | $1.63 | $100,001 | +85.52% | |||
| 2023-05-12 | director | 122,497 1.7522% | $1.63 | $200,001 | +85.52% | |||
| 2023-05-12 | director | 61,249 0.8761% | $1.63 | $100,001 | +85.52% | |||
| 2022-08-18 | 35,500 0.455% | $1.91 | $67,770 | -34.74% | ||||
| 2021-12-28 | director | 16,393 0.2296% | $3.08 | $50,436 | -33.78% | |||
| 2021-12-01 | director | 12,037 0.1613% | $3.51 | $42,288 | -42.02% | |||
| 2021-11-30 | director | 18,372 0.2426% | $3.55 | $65,221 | -43.31% | |||
| 2021-11-29 | director | 3,177 0.0426% | $3.55 | $11,278 | -42.08% | |||
| 2021-11-26 | director | 1,200 0.016% | $3.55 | $4,260 | -42.15% | |||
| 2021-11-24 | director | 18,328 0.24% | $3.55 | $65,064 | -43.09% | |||
| 2021-11-23 | director | 1,204 0.0163% | $3.55 | $4,274 | -41.20% | |||
| 2021-11-22 | director | 19,188 0.2545% | $3.54 | $67,874 | -41.87% | |||
| 2021-11-17 | director | 25,930 0.3678% | $3.85 | $99,961 | -41.35% | |||
| 2021-08-25 | director | 22,249 0.2924% | $4.19 | $93,246 | -30.83% | |||
| 2021-02-08 | CEO and President | 40,320 0.0223% | $0.62 | $24,998 | -76.39% | |||
| 2021-02-08 | director | 241,930 0.1339% | $0.62 | $149,997 | -76.39% | |||
| 2021-02-08 | director | 120,960 0.067% | $0.62 | $74,995 | -76.39% | |||
| 2021-02-08 | director | 80,640 0.0446% | $0.62 | $49,997 | -76.39% |
Insider Historical Profitability
| ROUBIN GARY S | director | 438902 1.6827% | $2.58 | 8 | 0 | <0.0001% |
| Slosman Marvin | CEO and President | 1453538 5.5726% | $2.58 | 2 | 0 | <0.0001% |
| MILINAZZO ALAN | President and CEO | 1423436 5.4572% | $2.58 | 6 | 0 | |
| BARER SOL J | director | 1141690 4.377% | $2.58 | 16 | 0 | |
| Stuka Paul | director | 248534 0.9528% | $2.58 | 11 | 1 | <0.0001% |
Institutional Investor Ownership
| OrbiMed | $5.06M | 8.56 | 2.13M | 0% | +$0 | 0.04 | |
| Nantahala Capital Management Llc | $4.9M | 8.29 | 2.07M | 0% | +$0 | 0.23 | |
| Marshall Wace | $4.28M | 7.46 | 1.86M | 0% | +$0 | <0.01 | |
| Soleus Capital Management, L.P. | $3.27M | 5.53 | 1.38M | 0% | +$0 | 0.01 | |
| Velan Capital | $2.14M | 3.63 | 904,029 | 0% | +$0 | 1.17 |